Occudo Quantitative Strategies LP Cidara Therapeutics, Inc. Transaction History

Occudo Quantitative Strategies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.43 - $0.91 $6,244 - $13,215	-14,522 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.67 - $1.39 $1,446 - $3,001	-2,159 Reduced 12.94%	14,522 $12,000
Q4 2021 Feb 14, 2022	SELL	$1.18 - $2.18 $8,277 - $15,292	-7,015 Reduced 29.6%	16,681 $21,000
Q3 2021 Nov 15, 2021	SELL	$1.48 - $2.35 $12,170 - $19,324	-8,223 Reduced 25.76%	23,696 $53,000
Q2 2021 Aug 16, 2021	BUY	$1.87 - $2.7 $10,802 - $15,597	5,777 Added 22.1%	31,919 $64,000

Q1 2021 May 14, 2021	BUY	$2.06 - $3.01 $16,892 - $24,682	8,200 Added 45.7%	26,142 $70,000
Q4 2020 Feb 16, 2021	BUY	$1.99 - $3.25 $35,704 - $58,311	17,942 New	17,942 $36,000

22.1M

2.7K

100

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $889M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.